# Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children

> **NCT05613062** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 20 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Modified Huang-Lian-Jie-Du Decoction (MHLJDD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05613062
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-11
- **Primary completion:** 2023-12
- **Final completion:** 2024-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05613062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05613062, "Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05613062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*